Clinical Trials · NCT03341429
Evaluation of Liraglutide 3.0mg in Patients With Poor Weight-loss and a Suboptimal Glucagon-like Peptide-1 Response
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- University College, London
- Enrollment
- 70
- Start date
- Aug 2018
- Locations
- 1 site, United Kingdom
- Primary endpoint
- %WL